Cationic mRNA lipid nanoparticles for ex vivo NanoCAR-T cell engineering
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Lipid nanoparticles (LNPs) are proposed as an attractive non‐viral alternative for mRNA‐based CAR‐T cell engineering. However, the impact of the LNP charge and the composition of the transfection medium remain to be fully explored. Here, charge‐neutral C12‐200 LNPs and cationic DOTAP(C12‐200) LNPs were compared for ex vivo transfection of activated primary human T cells. C12‐200 LNPs achieved efficient transfection with high cell viability in serum‐free medium supplemented with apolipoprotein E. Transfection efficiency correlated with low‐density lipoprotein receptor expression following T cell activation, suggesting receptor‐mediated uptake. In contrast, cationic LNPs demonstrated superior mRNA expression independent of medium composition or T cell activation state, albeit with reduced cytocompatibility. Both LNPs efficiently delivered anti‐CD20 nanoCAR mRNA into primary T cells, enabling potent cytotoxicity against CD20 + Raji cells in vitro. Together, our findings demonstrate that LNP charge, selected proteins in the culture medium, and T cell activation collectively play a critical role in ex vivo T cell engineering. Here, cationic LNPs offer the advantage of unspecific charge‐dependent transfection, inducing high mRNA expression independent on T cell activation status or complex cell culture media. These traits offer opportunities to extend expression kinetics, transfect less activated T cell phenotypes, and simplify CAR‐T cell manufacturing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Donors were not age- or sex-matched across experiments, and the number of donors was selected based on conventions in the primary T cell delivery literature rather than a formal power calculation.24,86,90,93,102”
From Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles (2026) · cites this paper as [93]
In the citing paper
“Recent work comparing cationic DOTAP-containing LNPs to charge-neutral formulations for ex vivo mRNA delivery to primary T cells93 describes an advantage of cationic charge in enabling transfection, independent of T cell activation status and culture medium composition.”
From Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles (2026) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
Dilliard, S. A., Cheng, Q., & Siegwart, D. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109256118 · Cited by 1,018 · cited 3×
“Likewise, Dilliard et al. demonstrated that LNP charge dictates the preferential adsorption of well-defined serum proteins in vivo, which influences binding to and transfection of specific cell types [ 38, 39 ].”
InfluentialThe dawn of mRNA vaccines: the COVID-19 case
Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504
Self-citationSebastiani, F., Yanez Arteta, M., Lerche, M., Porcar, L., Lang, C., Bragg, R. A., Elmore, C. S., Krishnamurthy, V. R., Russell, R. A., Darwish, T., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c10064 · Cited by 409 · cited 1×
“Opposed to cationic LNPs, ApoE is known to interact with the surface of charge-neutral ionizable LNPs (e.g., DLin-KC2-DMA LNPs) and promote transfection efficiency via LDL-R mediated endocytosis and improved cytosolic delivery [ 40, 46 , 71 ].”
Minnaert, A.-K., Vanluchene, H., Verbeke, R., Lentacker, I., De Smedt, S. C., Raemdonck, K., Sanders, N. N., & Remaut, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113900 · Cited by 157 · cited 1×
“In addition, the incorporation of self-amplifying mRNA or circular mRNA could further extend mRNA expression [ 83–85 ].”
Self-citationLuostarinen, A., Kailaanmäki, A., Turkki, V., Köylijärvi, M., Käyhty, P., Leinonen, H., Albers-Skirdenko, V., Lipponen, E., Ylä-Herttuala, S., Kaartinen, T., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.04.002 · Cited by 6 · cited 1×
“Nevertheless, the use of viral vectors entails important drawbacks such as limited packaging capacity, inconsistent transduction yields, and high manufacturing costs [ 11–13 ].”
Research works printed but not linked: 84
- 10.1126/science.aar6711 · DOI · Paper page
- 10.3389/fchem.2020.598100 · DOI
- 10.3389/fimmu.2023.1188049 · DOI · Paper page
- 10.1002/adhm.202301515 · DOI
- 10.1182/blood-2023-180666 · doi:10.1182/blood-2023-180666
- 10.46989/001c.124277 · DOI
- 10.1016/j.copbio.2018.01.025 · DOI · Paper page
- 10.1038/s41586‐023‐06243‐w · DOI · Paper page
- 10.3389/fimmu.2022.867013 · DOI
- 10.1038/s41392-021-00487-6 · DOI · Paper page
- 10.2147/IJN.S424723 · DOI
- 10.1016/j.biotechadv.2021.107760 · DOI
- 10.1002/btpr.3066 · DOI
- 10.1186/s12951‐024‐02630‐1 · DOI
- 10.1021/acs.nanolett.1c02503 · DOI · Paper page
- 10.1073/pnas.1809671115 · DOI · Paper page
- 10.1016/j.addr.2024.115215 · DOI
- 10.1016/j.ejpb.2024.114207 · DOI
- 10.3390/pharmaceutics14010213 · DOI
- 10.1021/acs.nanolett.8b01101 · DOI · Paper page
- 10.1016/j.omtm.2023.101139 · DOI · Paper page
- 10.1002/jbm.a.37705 · DOI · Paper page
- 10.1021/acs.nanolett.1c01353 · DOI · Paper page
- 10.1038/s41578‐021‐00358‐0 · DOI · Paper page
- 10.1136/jitc‐2022‐005189 · DOI
- 10.3389/fimmu.2024.1411393 · DOI
- 10.1016/j.ymthe.2019.01.018 · DOI · Paper page
- 10.1038/s41571‐023‐00832‐4 · DOI · Paper page
- 10.1038/s41467‐024‐54877‐9 · DOI
- 10.1016/j.biomaterials.2022.121510 · DOI
- 10.1021/acs.nanolett.9b04246 · DOI · Paper page
- 10.1021/acsbiomaterials.1c01532 · DOI
- 10.1038/s41565‐020‐0669‐6 · DOI · Paper page
- 10.1007/s40120-020-00208-1 · DOI · Paper page
- 10.1016/j.jconrel.2023.07.058 · DOI
- 10.1038/mt.2010.85 · DOI · Paper page
- 10.3389/fimmu.2022.876339 · DOI · Paper page
- 10.3892/ijmm.2023.5261 · DOI
- 10.18609/cgti.2020.121 · doi:10.18609/cgti.2020.121
- 10.3390/ijms21030883 · DOI
- 10.1016/j.jcyt.2021.08.005 · DOI
- 10.1038/s41565‐019‐0591‐y · DOI · Paper page
- 10.1038/s41598-018-30623-2 · DOI
- 10.1182/blood‐2013‐11‐540641 · DOI · Paper page
- 10.1101/2021.11.25.470053 · DOI
- 10.1016/S0022‐2275(20)32194‐5 · DOI
- 10.1016/j.jconrel.2023.08.014 · DOI
- 10.1038/s41467‐020‐14527‐2 · DOI · Paper page
- 10.1016/j.biopha.2018.11.121 · DOI
- 10.1200/JCO.2024.42.16_suppl.7027 · doi:10.1200/jco.2024.42.16_suppl.7027
- 10.1016/j.tips.2024.07.005 · DOI
- 10.37349/ei.2025.1003185 · DOI
- 10.3390/ijms19020403 · DOI
- 10.3390/cancers16142497 · DOI
- 10.1038/s41467‐019‐11642‐7 · DOI · Paper page
- 10.21873/invivo.13355 · DOI
- 10.1186/s12915‐022‐01386‐0 · DOI
- 10.3762/bjnano.15.83 · DOI
- 10.1039/D0CS01127D · DOI · Paper page
- 10.1016/j.jconrel.2016.03.029 · DOI
- 10.1021/acsabm.4c00103 · DOI
- 10.1039/C0CS00003E · DOI · Paper page
- 10.3390/nano8050270 · DOI · Paper page
- 10.1208/s12249‐022‐02294‐w · DOI · Paper page
- 10.1021/acsnano.7b04734 · DOI · Paper page
- 10.1039/D0BM01609H · DOI · Paper page
- 10.1136/jitc‐2021‐002555 · DOI
- 10.1038/s41551‐021‐00842‐6 · DOI · Paper page
- 10.1016/S2352‐3026(24)00273‐4 · DOI
- 10.1089/hgtb.2016.120 · DOI · Paper page
- 10.1074/jbc.AW119.008149 · DOI
- 10.1186/s40364‐022‐00359‐3 · DOI
- 10.1186/s40164‐023‐00435‐w · DOI
- 10.1002/smll.202304378 · DOI · Paper page
- 10.1016/j.nantod.2024.102518 · DOI
- 10.1126/science.abm0594 · DOI · Paper page
- 10.1038/s41568‐024‐00721‐7 · DOI · Paper page
- 10.1038/s41467‐018‐05096‐6 · DOI · Paper page
- 10.1038/s43018‐023‐00600‐4 · DOI · Paper page
- 10.3390/ijms23031833 · DOI
- 10.1038/s41598‐020‐74595‐8 · DOI
- 10.1038/s41416‐020‐01048‐4 · DOI · Paper page
- 10.1016/j.it.2016.06.004 · DOI
- 10.1083/jcb.202202011 · DOI
Cited by
Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles
Ramamurthy, A., Scimonelli, G., Murphy, W. L., & Saha, K. (2026) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2026.103081
Metadata
- Authors
- Harinck, L., De Munter, S., De Velder, M., Ingels, J., Berdecka, D., Lentacker, I., De Vos, W. H., Vandekerckhove, B., Braeckmans, K., & Raemdonck, K.
- Affiliations
- Laboratory for General Biochemistry and Physical Pharmacy Faculty of Pharmaceutical Sciences Ghent University Ghent Belgium
- Cancer Research Institute Ghent (CRIG) Ghent Belgium
- Cell Biology and Histology Lab University of Antwerp Antwerp Belgium
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2026-03-24
- Volume
- 13
- Issue
- 24
- ISSN
- 2198-3844
- Cited by
- 2
- References
- 5
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Funders
- Bijzonder Onderzoeksfonds UGent (BOF21‐GOA‐033)
- Stichting Tegen Kanker (C/2024/2562)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.